NCT00349089View on ClinicalTrials.gov

Trial on Refinement of Early Stage Lung Cancer Adjuvant Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

September 26, 2006

Primary Completion Date

April 14, 2014

Study Completion Date

April 14, 2014

Conditions
Non Small Cell Lung Cancer
Interventions
DRUG

Pemetrexed

Pemetrexed 500 mg/m2 d1 and Cisplatin 75 mg/m2 d1; q d22

DRUG

Cisplatin

"Pemetrexed 500 mg/m2 d1 and Cisplatin 75 mg/m2 d1; q d22~Comparator:~Vinorelbine 25 mg/m2 d1, 8, 15, 22; q d29 Cisplatin 50 mg/m2 d1, 8; q d29"

DRUG

Vinorelbine

Vinorelbine 25 mg/m2 d1, 8, 15, 22; q d29

Trial Locations (14)

3000

Department of Pulmonology (Respiratory Tumor Unit), University Hospital Gasthuisberg, Catholic University Leuven, Belgium., Leuven

3600

Ziekenhuis Oost Limburg, Genk

14109

Helios-Klinikum Emil von Behring, Berlin

22927

Lungenzentrum Großhansdorf, Großhansdorf

28325

Klinikum Bremen-Ost, Bremen

37075

Department of Hematology and Oncology, University of Göttingen, Göttingen

45122

Westdeutsches Tumorzentrum, Essen

58675

Lungenklinik Hemer, Hemer

65199

Dr. Horst Schmidt Klinik, Wiesbaden

69120

Clinic for thoracic diseases at the University of Heidelberg, Heidelberg

74245

Klinik Löwenstein, Löwenstein

Unknown

University of München, München

Oldenburg Hospital, Oldenburg

L-1210

Centre Hospitalier du Luxembourg, Luxembourg

All Listed Sponsors
lead

Thoraxklinik-Heidelberg gGmbH

OTHER

NCT00349089 - Trial on Refinement of Early Stage Lung Cancer Adjuvant Therapy | Biotech Hunter | Biotech Hunter